SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-001170
Filing Date
2019-01-24
Accepted
2019-01-24 17:00:30
Documents
7
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k012319_canfitebio.htm 6-K 23904
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL MEETING OF SHAR f6k012319ex99-1_canfite.htm EX-99.1 50786
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANYS SPECIAL M f6k012319ex99-2_canfite.htm EX-99.2 19403
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH f6k012319ex99-3_canfite.htm EX-99.3 973
5 GRAPHIC ex99-1_001.jpg GRAPHIC 4320
6 GRAPHIC prxy2.jpg GRAPHIC 184412
7 GRAPHIC prxy1.jpg GRAPHIC 154463
  Complete submission text file 0001213900-19-001170.txt   568148
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 19540531
SIC: 2834 Pharmaceutical Preparations